SCHEMBL1778731

SCHEMBL1778731

COc1ccc2c(c1)cc(-c1cc3cccnc3[nH]1)n2C1CSCCN1CCC=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 7/20 0.39
CDK1 P06493 2/20 0.39
CCNB1 P14635 2/20 0.39
CCNB2 O95067 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39
DRD2 P14416 2/20 0.36
DRD3 P35462 2/20 0.36
IGF1R P08069 2/20 0.35
IDO1 P14902 1/20 0.31
JAK2 O60674 1/20 0.30
LCK P06239 1/20 0.30
GSK3A P49840 1/20 0.30
GSK3B P49841 1/20 0.30
CDK7 P50613 1/20 0.30
BTK Q06187 1/20 0.30
LRRK2 Q5S007 1/20 0.30
AURKB Q96GD4 1/20 0.30
SYK P43405 1/20 0.30
KDM4E B2RXH2 1/20 0.30
HRH4 Q9H3N8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1778735 0.83 RIPK1 (0.41) RIPK1CDK1CCNB1CCNB2CCNB3
SCHEMBL1779933 0.72 DRD2 (0.44) RIPK1CDK1CCNB1CCNB2CCNB3
SCHEMBL1777680 0.72 RIPK1 (0.60) RIPK1CDK1CCNB1CCNB2CCNB3
SCHEMBL1777852 0.68 RIPK1 (0.49) RIPK1CDK1CCNB1CCNB2CCNB3
SCHEMBL1778988 0.67 RIPK1 (0.49) RIPK1CDK1CCNB1CCNB2CCNB3
SCHEMBL1778783 0.66 RIPK1 (0.48) RIPK1CDK1CCNB1CCNB2CCNB3
SCHEMBL1778606 0.66 RIPK1 (0.51) RIPK1CDK1CCNB1CCNB2CCNB3
SCHEMBL1781850 0.66 RIPK1 (0.51) RIPK1CDK1CCNB1CCNB2CCNB3
SCHEMBL1778908 0.66 RIPK1 (0.50) RIPK1CDK1CCNB1CCNB2CCNB3
SCHEMBL1779988 0.65 RIPK1 (0.44) RIPK1CDK1CCNB1CCNB2CCNB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943616-B2 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders AVENTIS PHARMACEUTICALS INC. (US) 2011-05-17 US disclosed
EP-1397360-A1 AZAINDOLES Aventis Pharma Limited (GB) 2004-03-17 EP disclosed
WO-2003000688-A1 AZAINDOLES AVENTIS PHARMA LIMITED (GB) 2003-01-03 WO disclosed